Dashboard
Manage Tickers

CMPSCOMPASS Pathways plc

Nasdaq compasspathways.com


$ 8.50 $ -0.09 (-1.05 %)    

Wednesday, 01-May-2024 15:59:45 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 422.58 $ -3.07 (-0.72 %)
DIA $ 378.81 $ 0.76 (0.2 %)
SPY $ 500.35 $ -1.63 (-0.32 %)
TLT $ 88.50 $ 0.65 (0.74 %)
GLD $ 213.80 $ 1.92 (0.91 %)
$ 8.48
$ 8.79
$ 0.00 x 0
$ 0.00 x 0
$ 8.34 - $ 8.80
$ 5.01 - $ 12.75
281,862
na
432.72M
$ 1.58
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-29-2024 12-31-2023 10-K
2 11-02-2023 09-30-2023 10-Q
3 08-03-2023 06-30-2023 10-Q
4 05-11-2023 03-31-2023 10-Q
5 02-28-2023 12-31-2022 10-K
6 11-03-2022 09-30-2022 10-Q
7 08-04-2022 06-30-2022 10-Q
8 05-10-2022 03-31-2022 10-Q
9 02-24-2022 12-31-2021 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

cantor-fitzgerald-reiterates-overweight-on-compass-pathways
Cantor Fitzgerald Reiterates Overweight on...
04/30/2024 14:16:35

Cantor Fitzgerald analyst Charles Duncan reiterates Compass Pathways (NASDAQ:CMPS) with a Overweight.

compass-pathways-and-journey-clinical-have-collaborated-to-inform-development-of-scalable-and-practical-delivery-and-healthcare-provider-training-model-for-comp360-psilocybin-treatment-if-approved-for-treatment-resistant-depression
Compass Pathways And Journey Clinical Have...
04/29/2024 10:38:05

cantor-fitzgerald-reiterates-overweight-on-compass-pathways
Cantor Fitzgerald Reiterates Overweight on...
04/19/2024 14:40:52

Cantor Fitzgerald analyst Charles Duncan reiterates Compass Pathways (NASDAQ:CMPS) with a Overweight.

cantor-fitzgerald-reiterates-overweight-on-compass-pathways
Cantor Fitzgerald Reiterates Overweight on...
04/18/2024 14:05:17

Cantor Fitzgerald analyst Charles Duncan reiterates Compass Pathways (NASDAQ:CMPS) with a Overweight.

psyched-dea-revisits-ban-on-two-psychedelics-farewell-russell-newcombe-podcast-episode-on-kanna--more
Psyched: DEA Revisits Ban On Two Psychedel...
04/17/2024 12:42:33

whos-who-in-cannabis-latest-executive-changes-you-should-know-about
Who's Who In Cannabis: Latest Executive Ch...
04/16/2024 00:22:56

micron-iris-energy-tripcom-group-and-other-big-stocks-moving-higher-on-monday
Micron, Iris Energy, Trip.com Group And Ot...
04/01/2024 17:02:28

U.S. stocks were lower, with the Dow Jones falling around 250 points on Monday.

morgan-stanley-initiates-coverage-on-compass-pathways-with-overweight-rating-announces-price-target-of-30
Morgan Stanley Initiates Coverage On Compa...
04/01/2024 10:49:20

Morgan Stanley analyst Vikram Purohit initiates coverage on Compass Pathways (NASDAQ:CMPS) with a Overweight rating and anno...

psychedelics-headlines-a-form-of-life-treating-chronic-pain-microdosing-and-more
Psychedelics Headlines: A Form Of Life, Tr...
03/30/2024 12:57:44

psyched-5-meo-dmt-for-depression-utah-hospitals-providing-therapy-elon-musk-and-metas-influence
Psyched: 5-MeO-DMT For Depression, Utah Ho...
03/29/2024 16:43:17

atai-life-sciences-q4-and-full-year-2023-results-steep-cash-drain-yet-2026-target-remains-update-on-psychedelic-pipeline
Atai Life Sciences Q4 And Full-Year 2023 R...
03/29/2024 13:20:35

compass-pathways-board-chair-and-co-founder-george-goldsmith-and-co-founder-ekaterina-malievskaia-step-down-from-board-of-directors-effective-march-29-2024
Compass Pathways Board Chair And Co-Founde...
03/28/2024 12:09:41

Compass Pathways plc (NASDAQ:CMPS) ("Compass"), a biotechnology company dedicated to accelerating patient access to evi...

psyched-lsd-psilocybin-as-breakthrough-therapies-14m-fed-grant-for-ibogaine-indianas-research-and-more
Psyched: LSD, Psilocybin As Breakthrough T...
03/20/2024 18:49:36

Core News & Articles
Reported Earlier, 'Indiana Lawmakers Send ...
03/14/2024 16:42:38

https://www.marijuanamoment.net/indiana-lawmakers-send-psilocybin-research-funding-bill-to-governor/   The Indiana legislatur...

fda-grants-cybin-breakthrough-therapy-status-for-major-depression-psilocybin-therapy-company-announces-positive-clinical-data--canadian-150m-private-placement
FDA Grants Cybin Breakthrough Therapy Stat...
03/13/2024 15:33:50

mindmed-receives-fda-breakthrough-therapy-designation-for-lsd-as-anxiety-treatment-shares-positive-results-about-related-clinical-trials
MindMed Receives FDA 'Breakthrough Therapy...
03/07/2024 18:35:02

psychedelics-2024-veterans-blessing-mental-health-paradigm-shift-providers-training-ketamine-mdma-bonds--more
Psychedelics 2024: Veterans Blessing, Ment...
03/06/2024 17:06:30

psyched-new-evidence-shows-psilocybin-as-anxiety-therapy-open-source-learning-for-therapists-enverics-licensing-deals-and-more
Psyched: New Evidence Shows Psilocybin As ...
03/04/2024 18:48:15

hc-wainwright--co-reiterates-buy-on-compass-pathways-maintains-120-price-target
HC Wainwright & Co. Reiterates Buy on Comp...
03/01/2024 19:20:34

HC Wainwright & Co. analyst Patrick Trucchio reiterates Compass Pathways (NASDAQ:CMPS) with a Buy and maintains $120 pri...

compass-pathways-shows-robust-2023-year-end-results-embraces-clinical-milestones-for-psilocybin-as-depression-treatment
Compass Pathways Shows Robust 2023 Year-En...
02/29/2024 20:16:26

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION